United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar JasonA25 (65.69) Submitted: 3/2/2007 12:30:21 PM : Outperform Start Price: $27.56 UTHR Score: +59.50

NICE GROWTH EST, POSITIVE CASH, WILL BE A NICE STOCK FOR THE FUTURE EVEN IF THERE IS A BEAR MARKET COMING UP.

Featured Broker Partners


Advertisement